$CGTX
Cognition Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$1.03
▼-2.83%-$0.030
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCognition Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is CGTX down today? It is at $1.03 (-2.83%), and our scanner flagged it 21 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CGTX spikes, and full due diligence on CGTX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CGTX 21 times in the last 30 days. Create a free account to track $CGTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CGTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CGTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Fletcher Aaron G.L. Director | Acquired (grant/award) | +25K 0.03% of company | added 44% | 81K | n/a | Jun 17, 26 |
Richstone Ellen B Director | Acquired (grant/award) | +25K 0.03% of company | added 43% | 84K | n/a | Jun 17, 26 |
Wallace Peggy Director | Acquired (grant/award) | +25K 0.03% of company | added 29% | 111K | n/a | Jun 17, 26 |
Monia Brett P Director | Acquired (grant/award) | +25K 0.03% of company | added 52% | 74K | n/a | Jun 17, 26 |
Khattar Jack A. Director | Acquired (grant/award) | +25K 0.03% of company | added 52% | 74K | n/a | Jun 17, 26 |
Doyle John Brendan Officer | Sold (automatic/other) | -9K | sold 1.4% | 619K | $11K at $1.28 | May 1, 26 |
Caggiano Anthony Officer | Bought (open market) | +10K 0.01% of company | added 1.2% | 875K | $11K at $1.11 | Apr 16, 26 |
Ricciardi Lisa Officer | Bought (open market) | +9K | added 0.5% | 1.72M | $10K at $1.10 | Apr 16, 26 |
Doyle John Brendan Officer | Bought (open market) | +10K 0.01% of company | added 1.6% | 628K | $11K at $1.13 | Apr 16, 26 |
Caggiano Anthony Officer | Sold (automatic/other) | -5K | sold 0.5% | 865K | $5K at $1.12 | Feb 15, 26 |
Doyle John Brendan Officer | Sold (automatic/other) | -2K | sold 0.3% | 618K | $2K at $1.12 | Feb 15, 26 |
Ricciardi Lisa Officer | Sold (automatic/other) | -6K | sold 0.3% | 1.71M | $7K at $1.12 | Feb 15, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on CGTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CGTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CGTX last traded at $1.03, down 2.83% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Cognition Therapeutics, Inc. Common Stock (CGTX) is next expected to report earnings on Thursday, November 5, 2026, about 46 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CGTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CGTX 21 times in the last 30 days.
CGTX (Cognition Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $99M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CGTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CGTX discussion
Sign in to ask a question or join the discussion.